Hiromi Wada, MD, PhD | Authors

Adjuvant Treatment of Early Stage Non–Small-Cell Lung Cancer

July 01, 1999

Cure rates for non–small-cell lung cancer (NSCLC) remain low and the prognosis for patients with even stage IA disease is poor. Complete surgical resection is still the first-line treatment for NSCLC, but many investigators

Postoperative Adjuvant Chemotherapy for Non-Small-Cell Lung Cancer

September 02, 1997

Given that no therapeutic methods of postoperative adjuvant chemotherapy for non-small-cell lung cancer have been established, we selected UFT (tegafur and uracil) for investigation because UFT is less injurious to the host